LFG
PTLA

Larson Financial Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Larson Financial Group’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-51
Closed -$1K – 875
2020
Q2 		$1K Hold
51
– – ﹤0.01% 671
2020
Q1 		$0 Hold
51
– – ﹤0.01% 693
2019
Q4 		$1K Hold
51
– – ﹤0.01% 563
2019
Q3 		$1K Hold
51
– – ﹤0.01% 534
2019
Q2 		$1K Hold
51
– – ﹤0.01% 483
2019
Q1 		$2K Hold
51
– – ﹤0.01% 401
2018
Q4 		$1K Buy
+51
New +$1.05K ﹤0.01% 460

Larson Financial Group's PTLA Position: Q3 2020 in Review

Larson Financial Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 51 shares — an estimated $1K sold.

Larson Financial Group first reported a position in PTLA in Q4 2018 and held it in 7 quarters. The position peaked at $2K in Q1 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Larson Financial Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Larson Financial Group sold 51 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1K.
  • Larson Financial Group first reported a position in Portola Pharmaceuticals, Inc. in Q4 2018 and held it in 7 quarters.
  • Larson Financial Group's Portola Pharmaceuticals, Inc. position peaked at $2K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Larson Financial Group's 13F filing for Q3 2020, filed 8 Oct 2020.